| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $28.4B | $27.2B | $26.5B | $25.8B | $23.1B | $4.7B | $3.8B | $4.0B |
| Cost of Revenue | $14.6B | $14.3B | $14.1B | $13.8B | $12.1B | $9.5B | $8.2B | $9.4B |
| Gross Profit | $13.8B | $12.9B | $12.4B | $12.0B | $10.9B | $2.1B | $1.6B | $1.8B |
| R&D Expense | $3.6B | $3.2B | $3.1B | $2.8B | $2.5B | $2.2B | $2.1B | $2.0B |
| SG&A Expense | $1.8B | — | — | — | — | — | — | — |
| Operating Income | $8.3B | $7.9B | $7.7B | $7.8B | $6.9B | $4.4B | $3.4B | $4.8B |
| Net Income | $7.0B | $7.2B | $6.9B | $6.5B | $5.9B | $1.1B | $0.7B | $0.9B |
| EPS (Basic) | $8.71 | $8.68 | $8.16 | $7.49 | $6.47 | $3.95 | $2.89 | $3.27 |
| EPS (Diluted) | $8.66 | $8.61 | $8.11 | $7.44 | $6.40 | $1.23 | $0.75 | $0.89 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $36.3B | $34.4B | $30.7B | $26.7B | $25.8B | $22.4B | $19.0B | $17.8B |
| Current Assets | $20.9B | $21.2B | $19.1B | $15.9B | $16.1B | $13.4B | $10.2B | $10.7B |
| Cash & Equivalents | $7.2B | $8.0B | $6.1B | $2.0B | $5.0B | $5.4B | $3.1B | $3.4B |
| Total Liabilities | $15.9B | $15.4B | $14.4B | $14.5B | $13.6B | $11.8B | $10.8B | $10.9B |
| Current Liabilities | $8.0B | $8.5B | $7.4B | $7.4B | $6.3B | $4.5B | $4.4B | $4.1B |
| Stockholders' Equity | $20.4B | $19.0B | $16.3B | $12.2B | $12.2B | $10.6B | $8.2B | $6.8B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $8.0B | $8.7B | $8.7B | $5.4B | $5.4B | $3.8B | $3.2B | $3.8B |
| Investing Cash Flow | $-2.8B | $-2.3B | $-1.5B | $-1.4B | $-1.2B | $-0.1B | $-0.4B | $0.6B |
| Capital Expenditures | $2.3B | $1.2B | $1.1B | $0.8B | $0.7B | $0.4B | $0.4B | $0.6B |
| Financing Cash Flow | $-6.0B | $-4.5B | $-3.0B | $-7.0B | $-4.6B | $-1.3B | $-3.1B | $-5.9B |